It is known that transcription factors mediate the distinct lineage differentiation of multi-potential hematopoietic stem cells. For instance, Pu.1 expression is essential for the development of monocytic cells while C/EBPalpha is essential for the development of granulocytic cells. However, the molecular basis for how one transcription factor is able to transactivate target gene expression in a multi-potential cell, while another factor is not, remains an enigma. The purpose of this proposal is to determine if the p300 co-activator protein and the SMRT co-repressor protein act as controlling factors to influence transcription factor mediated signals in hematopoietic stem cell that ultimately results in the determination of a specific lineage.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK009892-01
Application #
2770333
Study Section
Special Emphasis Panel (ZRG4-HEM-2 (02))
Program Officer
Bishop, Terry Rogers
Project Start
1999-02-01
Project End
Budget Start
1999-02-01
Budget End
2000-01-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Johansen, L M; Iwama, A; Lodie, T A et al. (2001) c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol Cell Biol 21:3789-806